BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Idoxuridine

Below is an extended Idoxuridine research listing. Click here to return to the Idoxuridine main in depth entry.

Recent Publications on Idoxuridine:

Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment.
Synchrotron stereotactic radiotherapy (SSR) is a treatment that involves...
Direct Link
25th September, 2008
Institut National de la Sante et de la Recherche Medicale, Unite 836,
Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Two mechanisms of radiotherapy resistance of major importance in head and...
Direct Link
19th September, 2008
Department of Otorhinolaryngology, Head and Neck Surgery, Radboud
Periocular dermatitis: a report of 401 patients.
Background Periocular contact dermatitis may appear as contact...
Direct Link
3rd September, 2008
Faculty of Medicine, Department of Dermatology, Venerology and
Isolation, characterization and genome sequence of a birnavirus strain from flounder Paralichthys olivaceus in China.
A birnavirus strain, Paralichthys olivaceus birnavirus (POBV), was...
Direct Link
21st August, 2008
State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of
Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus. 17th July, 2008
Institute for Antiviral Research, Department of Animal, Dairy and
Enhanced experimental tumor metastasis with age in senescence-accelerated mouse. 20th June, 2008
Department of Medical Biochemistry and Global COE Program, School of
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.
BACKGROUND: The vaccinia virus (VV) F2L gene encodes a functional...
Direct Link
23rd April, 2008
Department of Pediatrics, University of Alabama School of Medicine,
Supported synthesis and functionnalization of 2''-deoxyuridine by Suzuki-Miyaura cross-coupling.
The synthesis and modification of 2'-deoxyuridine has been realized under...
Direct Link
21st March, 2008
Institut de Chimie Organique et Analytique, UMR CNRS 6005, Universite
Characterization of mouse 3T3-swiss albino cells available in Japan: necessity of quality control when used as feeders. 14th March, 2008
Center for Pathogen Genomics, National Institute of Infectious Diseases,
Replication labeling with halogenated thymidine analogs.
In this unit, several basic protocols to identify sites of DNA replication...
Direct Link
21st February, 2008
Department of Biological Science Florida State University Tallahassee,
Use of halogenated precursors for simultaneous DNA and RNA detection by means of immunoelectron and immunofluorescence microscopy.
We have developed a novel approach for in situ labeling and detection of...
Direct Link
23rd January, 2008
Centre of Electron Microscopy, University of Lausanne, Rue du Bugnon 27,
Label-retaining cells in the rat submandibular gland.
To identify stem cells in salivary glands, label-retaining cells (LRCs)...
Direct Link
23rd January, 2008
Department of Oral Pathology, Osaka University Graduate School of
Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants.
The effect of phospholipid formulation and choice of surfactant on skin...
Direct Link
9th January, 2008
Unit for Drug Research and Development, North-West University,
Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
Previous studies in our laboratory have described increased and...
Direct Link
6th December, 2007
Department of Electrical Engineering and Computer Science, Case Western
Concomitant quantification of targeted drug delivery and biological response in individual cells. 31st August, 2007
University of Medicine and Dentistry of New Jersey, Newark, NJ 07101, USA.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional